Long-term disease stabilization by docetaxel plus estramustine for castration-resistant prostate cancer report of a case

Long-term disease stabilization by docetaxel plus estramustine for castration-resistant prostate cancer : report of a case

Chemotherapy with docetaxcel (DTX) plus estramustine (EMP) for castration-resistant prostate cancer (CRPC) was started 30 months after the patient, a 65-year-old man, was diagnosed as having advanced prostate cancer cT3aN1M1 (OSS) with an initial PSA of 490 ng/ml. Prostate biopsy specimens revealed...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 57(2011), 4 vom: 30. Apr., Seite 203-7
1. Verfasser: Kageyama, Susumu (VerfasserIn)
Weitere Verfasser: Iwaki, Hideaki, Masuda, Yoshikata, Yoshida, Tetsuya, Narita, Mitsuhiro, Okada, Yusaku
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2011
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Case Reports Journal Article Antineoplastic Agents Antineoplastic Agents, Alkylating Antineoplastic Agents, Hormonal Taxoids Docetaxel 15H5577CQD Estramustine 35LT29625A